Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00982163 · ClinicalTrials.gov registry record
A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season
A clinical trial of Allergic Conjunctivitis, sponsored by ORA.
- Completed
- Registry status
- 34
- Enrollment target
- 1
- Study location
NCT00982163 is a study of Allergic Conjunctivitis that has completed, run by ORA. The registered enrollment target is 34 participants, below the 133-participant average among 20 other Allergic Conjunctivitis trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00982163, a study of Allergic Conjunctivitis, has completed, sponsored by ORA.
- COMPLETED
- Registry status
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The study was designed to evaluate the pattern of seasonal allergic signs and symptoms consistent with ongoing ocular allergic inflammation during ragweed season. It was hypothesized that a pattern of ongoing ocular allergic inflammation existed in certain subjects.
Conditions Studied
Study Locations (1)
Massachusetts
- ORA, Inc. - North Andover
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00982163
The ClinicalTrials.gov registry entry for NCT00982163 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 20 other Allergic Conjunctivitis trials with a reported enrollment target (74% lower). The listed sponsor is ORA, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Allergic Conjunctivitis appearing as the primary indexed condition, and to 0 interventions.
NCT00982163 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00982163 about?
NCT00982163 is a clinical study titled "A Single-Center Evaluation of the Pattern of Allergic Signs and Symptoms During 4 Weeks in Ragweed Season". The study was designed to evaluate the pattern of seasonal allergic signs and symptoms consistent with ongoing ocular allergic inflammation during ragweed season. It was hypothesized that a pattern of ongoing ocular allergic inflammation existed in certain subjects.
What is the current status of trial NCT00982163?
This trial is currently completed. The enrollment target is 34 participants. The study started on 2008-08. Estimated completion is 2009-09.
What conditions does trial NCT00982163 study?
This clinical trial studies the following conditions: Allergic Conjunctivitis.
Who is sponsoring clinical trial NCT00982163?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00982163 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Allergic Conjunctivitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
RECRUITING · Phase 2
-
Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
RECRUITING · Phase 3
-
Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
RECRUITING · Phase 2
-
Evaluation of Efficacy of Coadministration of FOV1101-00 and Prednisolone Acetate in Patients With Mild Ongoing Ocular Allergic Inflammation
COMPLETED · Phase 2
-
Effectiveness of PR013 Topical Ophthalmic Drops Compared to Vehicle for the Treatment of Allergic Conjunctivitis
COMPLETED · Phase 2
-
Assessment of Alcon's Ocular Image Quantification System
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.